LMNA-related cardiocutaneous progeria syndrome
ORPHA: 363618
Overview
human disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with LMNA-related cardiocutaneous progeria syndrome, sourced from HPO and Orphanet clinical annotations.
Absent eyelashesHypertensionCongestive heart failureAortic valve stenosisMitral regurgitationCoronary artery atherosclerosisVentricular hypertrophyEmphysemaHypertriglyceridemiaIntracranial hemorrhagePremature graying of hairAbsent eyebrowAlopecia universalisAortic root aneurysmBasal cell carcinomaHypercholesterolemiaMitral valve calcificationAbnormality of the pulmonary arterySquamous cell carcinoma of the skinPapillary renal cell carcinomaSparse hairAbnormal intrahepatic bile duct morphologyAortic atherosclerotic lesionPulmonary carcinoid tumorSclerodermaLipoatrophyPremature skin wrinkling
Classification & Codes
Orphanet Code
ORPHA:363618LMNA-related cardiocutaneous progeria syndrome
| Orphanet | ORPHA:363618 |
| Treatments | 0 drug(s) |
| Symptoms on record | 27 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO